The OncLive® Conference page includes a listing of all conferences covered by OncLive®, including the ASCO, ESMO, SITC, EHA, ASH, and SABCS annual meetings, as well as the Chemotherapy Foundation Symposium and Miami Breast Cancer Conference, among many others. Conference coverage incorporates articles and interviews in written and video format.
March 16th 2024, 6:38pm
Quad Shot radiation plus a checkpoint inhibitor significantly improved local control vs Quad Shot alone and was well tolerated as a palliative treatment for patients with advanced head and neck cancer.
March 16th 2024, 6:16pm
The addition of pembrolizumab to chemotherapy led to a favorable overall survival benefit vs chemotherapy plus placebo in endometrial cancer.
March 16th 2024, 5:42pm
Social determinants of health were associated with geographical variations in the rates of cervical cancer in the United States.
March 16th 2024, 2:15pm
I-Chia (Daniel) Liu, MD, discusses surgical and local control outcomes following short-course radiation therapy and chemotherapy for rectal cancer.
March 15th 2024, 11:11pm
Robert W. Mutter, MD, discusses the nuances of partial breast irradiation in early-stage breast cancer.
March 15th 2024, 10:36pm
A post-hoc analysis showed dose escalation of radiation therapy was safe and elicited similar efficacy in intrahepatic cholangiocarcinoma.
March 15th 2024, 10:16pm
Charles B. Simone II, MD, FASTRO, FACRO, discusses advanced radiation techniques that could reduce cardiac toxicities.
March 15th 2024, 7:42pm
James Knight, MD, discusses the potential launch of a case series of patients with brain-metastatic prostate adenocarcinoma.
March 15th 2024, 7:38pm
Jason Efstathiou, MD, DPhil, discusses the role of tri-modality therapy in patients with muscle-invasive bladder cancer.
March 15th 2024, 7:38pm
Vlad Gabriel Zaha, MD, PhD, discusses the risk of cardiovascular toxicity in patients with lung cancer undergoing treatment with radiation.
March 15th 2024, 6:30pm
A case study of a patient with pre-B cell acute lymphoblastic leukemia showed helical tomotherapy with IMRT-based TBI is a viable option for organ sparing.
March 15th 2024, 5:47pm
PER® Miami Breast Cancer Conference
Hope S. Rugo, MD, draws on her own journey as a woman in oncology to provide insights on navigating career transitions and building support networks.
March 15th 2024, 1:00pm
PER® Miami Breast Cancer Conference
Stephanie L. Graff, MD, shares her journey to becoming an oncologist, advice for work-life balance, and ways to confront gender bias in medicine.
March 14th 2024, 10:00pm
Nina Sanford, MD, discusses how radiation could help improve QOL for patients with rectal cancer and situations when radiation or surgery could be omitted.
March 14th 2024, 9:55pm
Prolonged duration from neoadjuvant SCRT to surgery did not increase the risk of poor mesorectum specimen quality or post-operative morbidity in rectal cancer.
March 14th 2024, 9:42pm
Raj Singh, MD, discusses radiation therapy in patients with metastatic lung cancer, highlighting the evolution of treatment within this landscape.
March 14th 2024, 9:36pm
Idalid Franco, MD, MPH, discusses the use of radiation therapy and immunomodulatory agents in the treatment of endometrial cancer.
March 14th 2024, 8:30pm
Paul D. Brown, MD, gives a history of prophylactic cranial irradiation in small cell lung cancer and describes its standing in the treatment paradigm.
March 12th 2024, 7:42pm
US Prostate Cancer Conference (USPCC)
Tian Zhang, MD, MHS, discusses areas of ongoing debate regarding prostate cancer management.
March 12th 2024, 5:46pm
ESMO Targeted Anticancer Therapies Congress
TNO155 plus spartalizumab or ribociclib was well tolerated and demonstrated disease control in patients with advanced solid tumors.